The Effect of an Individual Empowerment Program Provided to Relatives of Schizophrenia Patients
1 other identifier
interventional
66
1 country
1
Brief Summary
Psychoeducation provided to family members caring for individuals with schizophrenia. Has been found to positively impact caregivers' psychological well-being and the effective management of schizophrenia patients.However, further experimental studies are recommended in this area, along with support for caregivers' psychological well-being. Primary caregivers, which includes both psychoeducation and applications aimed at developing coping skills, on the care burden, psychological well-being,and self-efficacy. Considering the gaps in the literature, the aim of this study is to evaluate the effect of an individual empowerment program applied to primary caregivers of patients diagnosed with schizophrenia on the burden of care, psychological well-being, and self-efficacy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable schizophrenia
Started May 2025
Shorter than P25 for not_applicable schizophrenia
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 15, 2025
CompletedFirst Submitted
Initial submission to the registry
September 7, 2025
CompletedFirst Posted
Study publicly available on registry
September 15, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 30, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
February 15, 2026
CompletedSeptember 15, 2025
September 1, 2025
7 months
September 7, 2025
September 7, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
The psychological well-being scale based on the individual empowerment program will be used to measure the care burden of individuals providing primary care to those diagnosed with schizophrenia. (time frame: 6 week)
The training will be conducted in person.
6 week
The care burden scale based on the individual empowerment program will be used to measure the care burden for individuals providing primary care to individuals diagnosed with schizophrenia. (Time frame: 6 weeks)
Face-to-face training will be provided.
6 week
The self-efficacy scale based on the individual empowerment program will be used to measure the care burden of individuals providing primary care to people diagnosed with schizophrenia. (time frame: 6 weeks)
The training will be conducted in person.
6 week
Study Arms (2)
experimental group
EXPERIMENTALData collection tools will be administered as a pre-test to individuals in the experimental and control groups. Individuals in the experimental group will receive individual empowerment training sessions as part of a six-session individual empowerment program.
control group
NO INTERVENTIONNo intervention will be performed on individuals in the control group; these individuals will receive standard discharge education.
Interventions
Data collection tools will be applied to individuals in the experimental and control groups as a pre-test. Individual empowerment training sessions will be applied to individuals in the experimental group totaling (6 sessions) as part of the individual empowerment program. No intervention will be performed on individuals in the control group; they will receive standard discharge education. Data collection tools will be applied to individuals in both groups for post-tests immediately after the experimental group completes all individual empowerment program sessions.
Eligibility Criteria
You may qualify if:
- Being the primary caregiver of a patient diagnosed with schizophrenia and other psychotic disorders Volunteering to participate in the study Being 18 years of age or older Being literate Not having a psychiatric illness (diagnosis) Not having a serious mental or physical disorder that prevents communication
You may not qualify if:
- Providing care to patients with severe organic brain syndrome such as alcohol or substance dependence, intellectual disability, dementia, or delirium, or with a previous or current general medical condition that could impair cognitive function Withdrawal from the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Istanbul Arel University
Istanbul, Cevizlibağ, 34010, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
zeynep dağ psychiatric nurse
Istanbul Arel University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Servis Hemşiresi
Study Record Dates
First Submitted
September 7, 2025
First Posted
September 15, 2025
Study Start
May 15, 2025
Primary Completion
November 30, 2025
Study Completion
February 15, 2026
Last Updated
September 15, 2025
Record last verified: 2025-09